---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- Atypical Antipsychotic

**Mechanism of Action (MOA):**
- Primarily blocks dopamine D4 and serotonin 5-HT2A receptors, with lesser effects on D2 receptors.

**Indications/Uses:**
- Treatment-resistant schizophrenia
- Reducing the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder

**Side Effects:**
- Sedation
- Weight gain
- Hypersalivation
- Dizziness
- Constipation

**Adverse Effects:**
- Agranulocytosis (requires regular blood monitoring)
- Seizures
- Myocarditis
- Metabolic syndrome

**Nursing Teaching and Implications:**
- Monitor white blood cell counts regularly due to risk of agranulocytosis.
- Educate about the importance of regular blood tests.
- Advise on managing weight and diet due to risk of metabolic syndrome.
- Discuss the importance of not abruptly discontinuing the medication.

**Contraindications:**
- History of clozapine-induced agranulocytosis
- Uncontrolled epilepsy
- Known hypersensitivity to clozapine